Related Experiment Video

Updated: Jun 23, 2026

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
08:43

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

Published on: July 28, 2012

NMP22 and surveillance for recurrent bladder cancer

Chad T Wilson

    JAMA
    |July 6, 2006
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
    11:02

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

    Published on: October 31, 2013

    Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
    05:19

    Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

    Published on: March 29, 2019

    Related Experiment Videos

    Last Updated: Jun 23, 2026

    An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
    08:43

    An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

    Published on: July 28, 2012

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
    11:02

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

    Published on: October 31, 2013

    Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
    05:19

    Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

    Published on: March 29, 2019

    Related Concept Videos

    Urinary Tract Infection IV: Nursing Management01:17

    Urinary Tract Infection IV: Nursing Management

    In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
    Acute Pyelonephritis II: Diagnostic Studies and Management01:28

    Acute Pyelonephritis II: Diagnostic Studies and Management

    Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...

    Articles linked to this work by shared authors, journal, and citation graph.

    Bayesian analysis of the early cold stored platelet transfusion following severe injury randomized clinical trial.

    Trauma surgery & acute care open·2026

    Association of alcohol use with helmet use in cyclists: analysis of the National Trauma Data Bank.

    Trauma surgery & acute care open·2026

    Long-term stability of moisture-capturing hydrogels by preventing metal-mediated degradation.

    Nature communications·2026

    A Case Study of AI-Enabled Software as a Medical Device Cleared by the FDA for Assessing Hemorrhage Risk Index (APPRAISE-HRI) after Trauma.

    NEJM AI·2026

    Emergency Medical Individual Clinician Volume and Mortality in Trauma Patients.

    JAMA surgery·2026

    Utilization of Cardiopulmonary Bypass in Trauma Patients: A Multi-Institutional Study of the American Association for the Surgery of Trauma.

    The American surgeon·2026

    Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial.

    JAMA·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us